Company Overview
Snapshot
Founded in May 2018 by Ron Shimoni, Eden Firuz, and Oded Shoseyov, Seekwell operates with 1–10 employees. The company has raised $4 million across one funding round from one investor. In February 2022, Seekwell secured $4 million in funding from BOL (Breath of Life) Pharma.
Business overview
Seekwell is a Health Tech & Life Sciences company specializing in cannabis-based therapeutics. The company has developed a technology that matches hemp-based formulations to specific medical and physical indications, utilizing pinpoint biochemical analysis and a proprietary AI-assisted process. Seekwell's model serves as a platform for various medical indications, aiming to provide partners with a stable supply chain for each product while expanding its range of targeted conditions. The company operates in the Pharmaceuticals sector, focusing on pain relief and cannabis-related products, with its product Blosm targeting consumers in the United States.
Strategic signal
In February 2022, Seekwell secured $4 million in funding from BOL (Breath of Life) Pharma. This investment signals strong strategic validation for Seekwell's AI-assisted approach to developing cannabis-based formulations and indicates a significant step towards commercializing its products within the medical cannabis market.
Log in to access full profile ›Company Intelligence Q&A
- When was Seekwell founded?
- Seekwell was founded in May 2018.
- Who are the founders of Seekwell?
- Seekwell was founded by Ron Shimoni, Eden Firuz, and Oded Shoseyov.
- What is Seekwell's primary focus?
- Seekwell focuses on developing cannabis-based therapeutics by matching hemp-based formulations to medical indications using AI-assisted biochemical analysis.
- Has Seekwell received any funding?
- Yes, Seekwell has raised $4 million across one funding round. In February 2022, the company received $4 million from BOL (Breath of Life) Pharma.
- What was a key product launch for Seekwell?
- In June 2021, Seekwell launched its first product, Blosm, which is specifically designed for women.